Curr Treat Options Oncol 2024 Jun
Treatment of Anemia in Lower-Risk Myelodysplastic Syndrome.
Related Questions
New answer by at University of Chicago (January 16, 2026)
Given the fact that the major treatment-emergent adverse events noted on the phase III IMERGE study in the imetelstat-treated arm were neutropenia (68% Grade 3+ tox) and throm...